Cingulate Inc.Cingulate Inc.Cingulate Inc.

Cingulate Inc.

No trades
See on Supercharts
Market capitalization
‪3.49 M‬USD
−30.3867USD
‪−23.53 M‬USD
‪2.38 M‬
Beta (1Y)
−1.25

About Cingulate Inc.

CEO
Shane J. Schaffer
Headquarters
Kansas City
Employees (FY)
13
Founded
2013
FIGI
BBG012G40MY2
Cingulate, Inc. operates as a clinical stage bio pharmaceutical company using Precision Timed Release, drug delivery platform technology to build a pipeline of next-generation pharmaceutical products. The firm initially focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). It identifies and evaluates additional therapeutic areas, PTR technology employed to develop future product candidates. Cingulate was founded by Shane J. Schaffer, Craig Steven Gilgallon, Raul R. Silva, Matthew N. Brams in 2013 and is headquartered in Kansas City, KS.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of CING is 0.8501 USD — it has decreased by 3.25% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Cingulate Inc. stocks are traded under the ticker CING.
Cingulate Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
CING stock is 5.59% volatile and has beta coefficient of −1.25. Check out the list of the most volatile stocks — is Cingulate Inc. there?
CING earnings for the last quarter are −6.00 USD per share, whereas the estimation was −7.40 USD resulting in a 18.92% surprise. The estimated earnings for the next quarter are −4.86 USD per share. See more details about Cingulate Inc. earnings.
Yes, you can track Cingulate Inc. financials in yearly and quarterly reports right on TradingView.
CING stock has fallen by 1.14% compared to the previous week, the month change is a 23.41% fall, over the last year Cingulate Inc. has showed a 96.10% decrease.
CING net income for the last quarter is ‪−6.93 M‬ USD, while the quarter before that showed ‪−5.98 M‬ USD of net income which accounts for −15.98% change. Track more Cingulate Inc. financial stats to get the full picture.
Today Cingulate Inc. has the market capitalization of ‪3.49 M‬, it has increased by 9.38% over the last week.
No, CING doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CING shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cingulate Inc. stock right from TradingView charts — choose your broker and connect to your account.
CING reached its all-time high on Dec 8, 2021 with the price of 103.0000 USD, and its all-time low was 0.7500 USD and was reached on Apr 15, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 13.00 employees. See our rating of the largest employees — is Cingulate Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Cingulate Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Cingulate Inc. stock shows the sell signal. See more of Cingulate Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.